首页 | 本学科首页   官方微博 | 高级检索  
检索        

川芎嗪可影响肿瘤坏死因子α刺激肝星状细胞结缔组织生长因子、核因子κB及相关基因产物的表达
引用本文:李艳芳,李孝生.川芎嗪可影响肿瘤坏死因子α刺激肝星状细胞结缔组织生长因子、核因子κB及相关基因产物的表达[J].中国临床康复,2011(46):8706-8711.
作者姓名:李艳芳  李孝生
作者单位:重庆医科大学附属第二医院消化内科,重庆市400010
基金项目:重庆市科委自然科学基金资助项目(2006BB5428) 课题名称:川芎嗪对HSC的影响及CTGF信号转导的调控机制探讨
摘    要:背景:川芎嗪延缓肝纤维化形成的机制尚不清楚。目的:观察川芎嗪对肿瘤坏死因子α刺激的肝星状细胞增殖及结缔组织生长因子、核因子κB及其相关基因产物白细胞介素6表达的影响。方法:体外培养HSC-T6细胞株,取对数生长期的细胞用于实验。实验分为4组:对照组仅加入细胞;TNF-α组加入10μg/L TNF-α;川芎嗪干预组先加入终浓度为10μg/L的TNF-α作用30min后,分别加入川芎嗪50,100,200,400,600,1000mg/L;PDTC组先加入终浓度为10μg/L的TNF-α作用30min后,再加入终浓度18μmol/L的核因子κB阻断剂PDTC。结果与结论:MTT结果显示100,200,400,600,1000mg/L的川芎嗪均能抑制HSC-T6增殖,且呈剂量依赖性。免疫细胞化学染色及Western blot检测发现10μg/L的肿瘤坏死因子α刺激后,HSC-T6细胞结缔组织生长因子、核因子κB及白细胞介素6的表达明显增多(P〈0.01或P〈0.05),200,400,600mg/L的川芎嗪及18μmol/L的PDTC均可明显降低肿瘤坏死因子α刺激后HSC-T6细胞结缔组织生长因子、核因子κB及白细胞介素6的表达(P〈0.01),且随着川芎嗪质量浓度的增加,抑制作用增强,PDTC的抑制作用最明显。相关性分析结果显示HSC-T6细胞结缔组织生长因子和核因子κB的表达呈正相关(r=0.980,P〈0.01)。说明川芎嗪可以抑制肝星状细胞结缔组织生长因子、核因子κB及白细胞介素6的表达,抑制肝星状细胞的增殖。

关 键 词:川芎嗪  肿瘤坏死因子α  肝星状细胞  结缔组织生长因子  核因子κB

Effects of tetramethylpyrazine on expression of connective tissue growth factor,nuclear factor kappa B and its related gene products in tumor necrosis factor-alpha stimulated hepatic stellate cells
Li Yan-fang,Li Xiao-sheng.Effects of tetramethylpyrazine on expression of connective tissue growth factor,nuclear factor kappa B and its related gene products in tumor necrosis factor-alpha stimulated hepatic stellate cells[J].Chinese Journal of Clinical Rehabilitation,2011(46):8706-8711.
Authors:Li Yan-fang  Li Xiao-sheng
Institution:Department of Gastroenterology,Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China
Abstract:BACKGROUND:Previous studies have shown that tetramethylpyrazine(TMP) can decrease expression of connective tissue growth factor(CTGF) ,nuclear factor kappa B(NF-κB) and delay the formation of hepatic fibrosis.But the mechanism and the correlation of CTGF and NF-κB was not clear.OBJECTIVE:To investigate the effects of TMP on expression of CTGF,NF-κB and its related gene product interleukin-6(IL-6) in tumor necrosis factor-alpha(TNF-α) stimulated hepatic stellate cells.METHODS:Hepatic stellate cell-T6(HSC-T6) was cultured to logarithmic growth phase for experiments.Cells were divided into four groups:control group:only cells were added;TNF-α group:10 μg/L TNF-α was added;TMP intervention group:pretreated with 10 μg/L TNF-α for 30 minutes and then 50,100,200,400,600,1 000 mg/L TMP was added;PDTC group:pretreated with 10 μg/L TNF-α for 30 minutes,and then stimulated with 18 μmol/L PDTC,a blocker of NF-κB.RESULTS AND CONCLUSIONS:MTT assay results showed that TMP inhibited the proliferation of HSC-T6 at a concentration of 100,200,400,600,and 1 000 mg/L in a concentration dependent manner(P 0.05) .Immunocytochemical staining and western blot analysis showed that 200,400,600 mg/L TMP and 18 μmol/L PDTC could decrease the expression of TNF-α-induced CTGF,NF-κB and IL-6(P〈0.01) in HSC-T6 cells and with increasing concentrations of TMP,the inhibitory effects were enhanced,and PDTC could inhibit their expression effectively.Correlation analysis showed that the expression of cTGF and NF-κB in HSC-T6 cells was positively correlated(r=0.980,P〈0.01) .These data indicated that TMP could inhibit the expression of cTGF,NF-κB and IL-6 in hepatic stellate cells and inhibit the proliferation of hepatic stellate cells.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号